Daxor (NYSEAMERICAN:DXR) Stock Passes Below 200 Day Moving Average – Time to Sell?

Daxor Co. (NYSEAMERICAN:DXRGet Free Report)’s stock price crossed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $12.47 and traded as low as $12.25. Daxor shares last traded at $12.25, with a volume of 3,009 shares trading hands.

Daxor Trading Down 0.8%

The stock has a fifty day moving average of $13.25 and a 200-day moving average of $12.47.

About Daxor

(Get Free Report)

Daxor Corporation (NYSE American: DXR) is a medical technology company specializing in diagnostic solutions for the measurement of blood volume. The company’s proprietary BVA-100 and BVA-200 systems utilize radiolabeled albumin tracers to provide clinicians with precise determinations of total blood volume, plasma volume and red blood cell volume. By offering quantitative assessments rather than estimations, Daxor’s platform aims to improve clinical decision-making for conditions that involve fluid balance and hemodynamic status.

In addition to its analytical instruments, Daxor maintains a CLIA-certified laboratory service that processes in-vitro diagnostic reagents and delivers detailed blood volume reports directly to healthcare providers.

See Also

Receive News & Ratings for Daxor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Daxor and related companies with MarketBeat.com's FREE daily email newsletter.